BSE
MARKET ANALYSIS NEWS CORPORATE INFORMATION CORPORATE ACTIONS OTHER MARKETS
Your Result on : Company News Details
Cohance Lifesciences Ltd Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
543064
ISIN Demat
INE03QK01018
Book Value (Rs)
60.8611266
NSE Symbol
COHANCE
Divident Yield %
0
Market Cap
(Rs In Cr.)
37,507
P/E (TTM)
138.08
EPS (TTM)
7.1
Face Value
(Rs)
1
Back
Cohance Lifesciences appoints Yann D'Herve as CEO - CDMO Business
28-Jul-25   Hrs IST

The Board of Cohance Lifesciences has appointed Yann D'Herve as Chief Executive Officer – CDMO Business, and Senior Management Personnel of the Company, with effect from 01 August 2025. Yann will be based out of New Jersey, United States of America.

Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, developed & powered by C-MOTS Infotech (ISO 9001:2015 certified)